Nuo Therapeutics Inc
OTC:AURX
Nuo Therapeutics Inc
Inventory
Nuo Therapeutics Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Nuo Therapeutics Inc
OTC:AURX
|
Inventory
$150.4k
|
CAGR 3-Years
-17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-13%
|
|
|
Charles River Laboratories International Inc
NYSE:CRL
|
Inventory
$299.1m
|
CAGR 3-Years
5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
|
Gartner Inc
NYSE:IT
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
Inventory
$10.5m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
5%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Inventory
$2.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
26%
|
|
Nuo Therapeutics Inc
Glance View
Nuo Therapeutics, Inc. is a biomedical company. The company is headquartered in Houston, Texas and currently employs 7 full-time employees. The company went IPO on 2017-01-19. The firm's Aurix System is a biodynamic hematogel that harnesses a patient's innate regenerative abilities for the management of a variety of wounds. The firm commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company’s Aurix point of care technology for the safe and efficient separation of autologous blood to produce a platelet-based therapy for the chronic wound care market. The firm is marketing its products primarily within the United States. Nuo Therapeutics' s Aurix System produces a platelet rich plasma (PRP), gel at the point of care using the patient’s own platelets and plasma. The Aurix comprises a natural, endogenous complement of protein and non-protein signal molecules that contribute to effective healing.
See Also
What is Nuo Therapeutics Inc's Inventory?
Inventory
150.4k
USD
Based on the financial report for Sep 30, 2025, Nuo Therapeutics Inc's Inventory amounts to 150.4k USD.
What is Nuo Therapeutics Inc's Inventory growth rate?
Inventory CAGR 10Y
-13%
Over the last year, the Inventory growth was -10%. The average annual Inventory growth rates for Nuo Therapeutics Inc have been -17% over the past three years , and -13% over the past ten years .
